According to Harpoon Therapeutics
's latest financial reports the company has a price-to-book ratio of 108.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 42.4 | 849.22% |
2022-12-31 | 4.47 | 4.9% |
2021-12-31 | 4.26 | -45.99% |
2020-12-31 | 7.88 | 101.65% |
2019-12-31 | 3.91 | |
2018-12-31 | N/A | |
2017-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | 2.86 | -97.36% | ๐บ๐ธ USA |